Publications

  • Trishna Desai, Ruth Travis, and Karl Smith-Byrne,
    Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics,
    eBioMedicine, Jun 2024, Vol , pg [PMID:38878676].
  • James Yarmolinsky, Kostas Tsilidis, and Richard M Martin et al.,
    Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis,
    eBioMedicine, Feb 2024, Vol , pg [PMID:38301482].
  • Eleanor Watts et al.,
    Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study,
    BJC, Dec 2023, Vol 130, pg 114-124 [PMID:38057395].
  • Anqi Wang, Chris Haiman, Dave Conti et al.,
    Characterizing prostate cancer risk prediction through multi-ancestry genome-wide discovery of 187 novel risk variants,
    Nature Genetics, Nov 2023, Vol , pg [PMID:37945903].
  • Yijun Tian, Dandan Dong, Lang Wu, Jong Y Park, Gong-Hong Wei, Liang Wang,
    Combined CRISPR and proteomics screening reveal a cohesin-CTCF bound allele contributing to increased expression of RUVBL1 and prostate cancer progression,
    Am J Hum Genet, Aug 2023, Vol , pg [PMID:37541187].
  • Darst, Conti, Haiman et al.,
    Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry,
    AJHG, Jul 2023, Vol , pg [PMID:37311464].
  • Lindström, Pharaoh, Kar, Pasaniuc, Kraft et al,
    Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions,
    JNCI, Jun 2023, Vol 115(6), pg 712-732 [PMID:36929942].
  • Nabila Kazmi, Elena Valeeva, Gulshat Khasanova, Sarah Lewis, Denis Plotnikov, The PRACTICAL Consortium,
    Blood pressure, calcium channel blockers and the risk of prostate cancer: A Mendelian randomisation study,
    Cancer Causes Control, May 2023, Vol , pg [PMID:37178364].
  • James Yarmolinsky et al.,
    Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis,
    Diabetologia, May 2023, Vol , pg [PMID:37171501].
  • Fei Chen, David Conti, Chris Haiman,
    Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry,
    European Urology, Mar 2023, Vol , pg [PMID:36872133].
  • Ellie Watts,
    Circulating IGFs and IGFBPs and risks of overall, aggressive and early-onset prostate cancer risk: individual participant data from 20 prospective studies and Mendelian randomization analysis,
    IJE, Feb 2023, Vol 52(1), pg 71-86 [PMID:35726641].
  • Si Fang, James Yarmolinsky, Dipender Gill, George Davey Smith, Tom R Gaunt, Tom G Richardson,
    Genetically proxied PCSK9 inhibition provides indication of lower prostate cancer risk: a Mendelian randomization study,
    PLoS Med, Jan 2023, Vol 20(1), pg [PMID:36595504].
  • Yarmolinsky, Amos, Martin, Geroge,
    Germline TYK2 mutation and cancer risk,
    IJC, Dec 2022, Vol 151(12), pg 2155-2160 [PMID:35747941].
  • Loic Yengo, Sonja Berndt et al,
    A saturated map of common genetic variants associated with human height from 5.4 million individuals of diverse ancestries,
    Nature, Oct 2022, Vol 610, pg 704-712 [PMID:36224396].
  • Justin R. Gregg et al,
    Coffee intake, caffeine metabolism genotype, and survival in men with prostate cancer,
    European Urology, Aug 2022, Vol , pg [PMID:35995710].
  • Ellie Watts,
    Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia,
    IJC, May 2022, Vol , pg [PMID:35579976].
  • Hui-Yi Lin, Jong Park,
    Intake patterns of specific alcoholic beverages by prostate cancer status,
    Cancers, Apr 2022, Vol , pg [PMID:35454886].
  • Fernanda Morales-Berstein, Richard Martin,
    Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study,
    eLife, Mar 2022, Vol , pg [PMID:35346416].
  • Tyler Seibert et al,
    Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score,
    Prostate Cancer and Prostatic Diseases, Feb 2022, Vol , pg [PMID:35152271].
  • James Yarmolinsky, Richard Martin et al,
    Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers,
    PLOS medicine, Feb 2022, Vol , pg [PMID:35113855].
  • Anna Ioannidou, Kostas Tsilidis, Verena Zuber et al.,
    The relationship between Lipoprotein A and Prostate Cancer risk: A multivariable Mendelian randomization study.,
    PLOS medicine, Jan 2022, Vol , pg [PMID:35085228].
  • Emmanouil Bouras, Kostas Tsilidis et al,
    Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis,
    BMC Med., Jan 2022, Vol , pg [PMID:35012533].
  • Questa Karlsson, Mark Brook, Zsofia Kote-Jarai,
    Rare germline variants in ATM predispose to prostate cancer: A PRACTICAL Consortium study,
    Eur Urol Onc, Aug 2021, Vol 4(4), pg 570-579 [PMID:33436325].
  • Charlotte Salmon, Lixin Song, Marie-Elise Parent,
    Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL Consortium,
    European Journal of Epidemiology, Jul 2021, Vol 36(9), pg 913-925 [PMID:34275018].
  • Chen, Lindstrom,
    Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals,
    Human Genetics and Genomics Advances, Jul 2021, Vol 2(3), pg [PMID:34355204].
  • Tyler Seibert,
    Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24,
    Prostate Cancer and Prostatic Diseases, Jun 2021, Vol , pg [PMID:34127801].
  • Csilla Sipeky, Teuvo L. J. Tammela, Anssi Auvinen, Johanna Schleutker,
    Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease,
    Prostate Cancer and Prostatic Diseases, May 2021, Vol , pg [PMID:34012061].
  • Victoria Wang, Christopher Sweeney et al.,
    A Polymorphism in the Promoter of FRAS1 Gene is Associated with Metastatic Prostate Cancer.,
    The Prostate, May 2021, Vol , pg [PMID:33956343].
  • Ellie Watts,
    Circulating insulin?like growth factor?I, total and free testosterone concentrations and prostate cancer risk in 200?000 men in UK Biobank,
    Int J Cancer, May 2021, Vol 148(9), pg 2274-2288 [PMID:33252839].
  • Hui-Yi Lin, Jong Park,
    KLK3 SNP-SNP interactions and SNP-interaction polygenic risk score for prediction of prostate cancer aggressiveness,
    Scientific Reports, Apr 2021, Vol 11(1), pg 9264 [PMID:33927218].
  • Tyler Seibert,
    Common genetic and clinical risk factors: Association with fatal prostate cancer in the Cohort of Swedish Men,
    Prostate Cancer and Prostatic Diseases, Mar 2021, Vol , pg [PMID:33723363].
  • Tyler Seibert et al.,
    Polygenic hazard score is associated with prostate cancer in multi-ethnic populations,
    Nat. Comms., Feb 2021, Vol 12(1), pg 1236 [PMID:33623038].
  • Hui-Yi Lin, Jong Y. Park et al.,
    Alcohol Intake and Alcohol-SNP Interactions Associated with Prostate Cancer Aggressiveness,
    Journal of Clinical Medicine, Feb 2021, Vol 10(3), pg [PMID:33540941].
  • Tyler Seibert,
    Additional SNPs improve the performance of a polygenic hazard score for prostate cancer,
    Prostate Cancer and Prostatic Diseases, Jan 2021, Vol 24(2), pg 532-541 [PMID:33420416].
  • David Conti, Lilit Chemenyan, Burcu Darst, Chris Haiman,
    Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction,
    Nat. Genet., Jan 2021, Vol 53(1), pg 65-75 [PMID:33398198].
  • Andreia Brandão, Manuel Teixeira,
    The CHEK2 variant c.349A>G is associated with prostate cancer risk and carriers share a common ancestor,
    Cancers, Nov 2020, Vol , pg [PMID:33158149].
  • Roshan Karunamuni, Tyler Seibert et al.,
    African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer ,
    Int J Cancer, Sep 2020, Vol , pg [PMID:32930425].
  • Lang Wu et al,
    An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk,
    Nature Communications, Aug 2020, Vol 11(1), pg 3905 [PMID:32764609].
  • Yan Dora Zhang, Amber Wilcox, Nilanjan Chatterjee, Montserrat Garcia-Closas,
    Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers,
    Nat. Comms, Jul 2020, Vol 11(1), pg 3353 [PMID:32620889].
  • Tyler Seibert et al.,
    A genetic hazard score to personalize prostate cancer screening, applied to population data,
    CEBP, Jun 2020, Vol 29(9), pg 1731-1738 [PMID:32581112].
  • Tyler Seibert et al.,
    The effect of sample size on polygenic hazard models for prostate cancer,
    EJHG, Jun 2020, Vol , pg [PMID:32514134].
  • Ahmed M, Goh C, Saunders E, Cieza-Borrella C; PRACTICAL consortium, Kote-Jarai Z, Schumacher FR, Eeles R.,
    Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT,
    Prostate Cancer Prostatic Dis, May 2020, Vol 23(2), pg 333-342 [PMID:31776447].
  • Kazmi N, Haycock P, Tsilidis K, Lynch BM, Truong T; PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS, Martin RM, Lewis SJ.,
    Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian randomization study based on 79,148 prostate cancer cases and 61,106 controls,
    Int J Epi., Apr 2020, Vol 49(2), pg 587-596 [PMID:31802111].
  • Ben Hollis, Felix Day, Deborah Thompson, John Perry,
    Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan.,
    Nature Communications, Mar 2020, Vol 11(1), pg 1536 [PMID:32210231].
  • Sarah L. Kerns, Catharine M. L. West,
    Radiogenomics Consortium Genome Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy,
    JNCI, Feb 2020, Vol 112(2), pg 179-190 [PMID:31095341].
  • Xia Jiang, Richard Martin et al.,
    Allergy, asthma and the risk of breast and prostate cancer: a Mendelian randomization study,
    Cancer Causes Control, Jan 2020, Vol 31(3), pg 273-282 [PMID:32006205].
  • Deborah Thompson, John Perry et al,
    Genetic predisposition to mosaic Y chromosome loss in blood.,
    Nature, Nov 2019, Vol 575(7784), pg 652-657 [PMID:31748747].
  • Lang Wu et al,
    Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk,
    Cancer Research, Sep 2019, Vol 79 (18), pg 4592-4598 [PMID:31337649].
  • Chey Loveday, Amit Sud, Kevin Litchfield et al.,
    Runs of Homozygosity and Testicular Cancer Risk,
    Andrology, Jul 2019, Vol 7(4), pg 555-564 [PMID:31310061].
  • Lang Wu, Jirong Long, Yingchang Lu, et al.,
    Identification of novel susceptibility loci and genes for prostate cancer risk: A transcriptome-wide association study in over 140,000 European descendants,
    Cancer Research, May 2019, Vol 79(13), pg 3192-3204 [PMID:31101764].
  • Philip Law, Richard Houlston et al.,
    Association analyses identify 31 new risk loci for colorectal cancer susceptibility,
    Nature Communications, May 2019, Vol 10, pg [PMID:31089142].
  • Rhona Benyon et al,
    Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial.,
    Int J Cancer, Apr 2019, Vol 144(8), pg 1918-1928 [PMID:30325021].
  • Karl Smith Byrne, Paul N. Appleby, Timothy J. Key, et al.,
    The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European Prospective Investigation into Cancer & Nutrition,
    Annals of Oncology, Apr 2019, Vol 30(6), pg 983-989 [PMID:31089709].
  • Xia Jiang, Hilary Finucane, Fredrick Schumacher, et al.,
    Shared heritability and functional enrichment across six solid cancers,
    Nature Communications, Jan 2019, Vol 10(1), pg 431 [PMID:30683880].
  • Srilakshmi Srinivasan, Judith Clements, Joytsna Batra,
    Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.,
    Clinical Chemistry, Jan 2019, Vol , pg [PMID:30538125].
  • Charleen D. Adams et al.,
    Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study,
    CEBP, Jan 2019, Vol 28(1), pg 208-216 [PMID:30352818].
  • Niki Dimou, Konstantinos Tsilidis et al.,
    Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study,
    IJE, Dec 2018, Vol , pg [PMID:30597039].
  • Vanessa Tan et al,
    Reassessing the Association between Circulating Vitamin D and IGFBP-3: Observational and Mendelian Randomization Estimates from Independent Sources.,
    CEBP, Dec 2018, Vol 27(12), pg 1462-1471 [PMID:30072546].
  • Amit Sud, Richard Houlston et al.,
    Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma,
    Blood, Nov 2018, Vol 132(19), pg 2040-2052 [PMID:30194254].
  • Marco Martejcic,
    Germline Variation at 8q24 and Prostate Cancer Risk in Men of European Ancestry,
    Nature Communications, Nov 2018, Vol 9(1), pg 4616 [PMID:30397198].
  • James Yarmolinsky, Carolina Bonilla, Philip C Haycock, et al.,
    Mendelian randomization does not support serum calcium in prostate cancer risk,
    Cancer Causes and Control, Nov 2018, Vol 29(11), pg 1073-1080 [PMID:30306355].
  • Nicholas Mancuso, Bogdan Pasaniuc et al.,
    Large-scale transcriptome-wide association study identifies new prostate cancer risk regions.,
    Nat. Comms, Oct 2018, Vol 9(1), pg 4079 [PMID:30287866].
  • Molly Went et al.,
    Identification of multiple risk loci and potential regulatory mechanisms influencing susceptibility to multiple myeloma,
    Nature Communications, Sep 2018, Vol 9(1), pg 3707 [PMID:30213928].
  • Johanna Schleutker et al.,
    Synergistic interaction of HOXB13 and CIP2A predispose to aggressive prostate cancer,
    Clincial Cancer Research, Sep 2018, Vol , pg [PMID:30181389].
  • James Yarmolinsky, Carolina Bonilla, Philip C Haycock, et al.,
    Circulating selenium and prostate cancer risk: a Mendelian randomization study,
    JNCI, Sep 2018, Vol , pg [PMID:29788239].
  • Elina Kaikkonen, …, Johanna Schleutker.,
    ANO7 is associated with aggressive prostate cancer,
    IJC, Aug 2018, Vol , pg [PMID:30157291].
  • Sarah Benafif, Zsofia Kote-Jarai, Rosalind A. Eeles,
    A Review of Prostate Cancer Genome-Wide Association Studies (GWAS),
    CEBP, Aug 2018, Vol 27(8), pg 845-857 [PMID:29348298].
  • Chey Loveday, Kevin Law, Kevin Litchfield et al.,
    Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology,
    European Urology, Jun 2018, Vol 74(3), pg 248-252 [PMID:29935977].
  • Tokhir Dadaev, Edward J. Saunders, Zsofia Kote-Jarai et al.,
    Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants,
    Nature Communications, Jun 2018, Vol , pg [PMID:29892050].
  • Fredrick R. Schumacher, Ali Amin Al Olama, Sonja I. Berndt, et al,
    Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci,
    Nat Genet., Jun 2018, Vol 50(7), pg 928-936 [PMID:29892016].
  • Hui-Yi Lin, Jong Park,
    AA9int: SNP interaction pattern search using non-hierarchical additive model set,
    Bioinformatics, Jun 2018, Vol 34(24), pg 4141-4150 [PMID:29878078].
  • Jayaram Vijayakrishnan, James Studd, Richard S. Houlston,
    Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.,
    Nature Communications, Apr 2018, Vol 9(1), pg 1340 [PMID:29632299].
  • Verena Zuber, et al.,
    Identification of shared genetic variants between schizophrenia and lung cancer,
    Scientific reports, Jan 2018, Vol 8(1), pg 674 [PMID:29330379].
  • Tyler Seibert, Ian G. Mills, Verena Zuber, Ole A. Andreassen, Wes K. Thompson, Anders M. Dale,
    Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.,
    BMJ, Jan 2018, Vol 360:j5757, pg [PMID:29321194].
  • FitzGerald LM, Zhao S, et al.,
    Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.,
    Prostate Cancer Prostatic Dis, Jan 2018, Vol (Epub ahead of print), pg [PMID:29298992].
  • Amit Sud, Richard Houlston, Nick Orr, Anthony Swerdlow,
    Genome-wide association study of Hodgkin lymphoma identifies key regulators of disease susceptibility,
    Nature Communications, Dec 2017, Vol 8(1), pg 1892 [PMID:29196614].
  • Vasiliki I. Dimitrakopoulou, Konstantinos K Tsilidis, Richard Martin et al,
    Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.,
    BMJ, Oct 2017, Vol 359:j4761, pg [PMID:29089348].
  • Artitaya Lophatananon, Kenneth Muir, et al.,
    Height, selected genetic markers and prostate cancer risk : results from the PRACTICAL consortium,
    British Journal of Cancer, Aug 2017, Vol 117(5), pg 734-743 [PMID:28765617].
  • David V. Conti, Christopher A. Haiman, et al.,
    Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry,
    JNCI, Aug 2017, Vol 109(8), pg [PMID:29117387].
  • Kevin Litchfield, Richard S Houlston, Clare Turnbull, et al.,
    Identification of 19 new risk loci reveals gene regulatory mechanisms determining susceptibility to testicular germ cell tumour,
    Nat Genet., Jun 2017, Vol 49(7), pg 1133-1140 [PMID:28604728].
  • Philip Haycock, Caroline Relton, Richard Martin, George Davey-Smith, et al.,
    The association between genetically predicted telomere length and risk of non-communicable diseases,
    JAMA Oncology, May 2017, Vol 3(5), pg 636-651 [PMID:28241208].
  • John Perry, Deborah Thompson, Ken Ong,
    Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk,
    Nat Genet., Apr 2017, Vol 49(6), pg 834-841 [PMID:28436984].
  • Verena Zuber, Ole Andreassen, Ian Mills,
    Bromodomain protein 4 discriminates super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer,
    BMC Genomics, Mar 2017, Vol 18(1), pg [PMID:28359301].
  • Jianxin Shi, Nilanjan Chatterjee, et al.,
    Winner’s Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data,
    PloS Genetics, Dec 2016, Vol , pg [PMID:28036406].
  • Hui-Yi Lin, Jong Y. Park et al.,
    SNP Interaction Pattern Identifier (SIPI): An Approach to the Intensive Search for SNP-SNP Interaction Patterns,
    Bioinformatics, Dec 2016, Vol , pg [PMID:28039167].
  • Amy E. Taylor, Richard M. Martin, Janet L Stanford, Irene Shui, et al.,
    Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis,
    IJC, Oct 2016, Vol 140(2), pg 322-328 [PMID:27741566].
  • Antje Rinckleb, Manuel Luedeke, Liesel FitzGerald, Christiane Maier, et al.,
    Prostate cancer risk regions in 8q24 and 17q24 are differentially associated with somatic TMPRSS2-ERG fusion status,
    Hum Mol Genet, Oct 2016, Vol , pg [PMID:27798103].
  • Clair Brunner, Neil M Davies, Richard M Martin,
    Alcohol Consumption and Prostate Cancer Incidence and Progression: a Mendelian Randomization Study,
    IJC, Oct 2016, Vol 140(1), pg 75-85 [PMID:27643404].
  • Chris Amos, et al.,
    The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers,
    CEBP, Oct 2016, Vol 26(1), pg 126-135 [PMID:27697780].
  • Melissa Southey et al.,
    PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS,
    JMG, Sep 2016, Vol 53(12), pg 800-811 [PMID:27595995].
  • Fehringer G, Kraft P, Pharoah PD, Eeles RA et al.,
    Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.,
    Cancer Res, Sep 2016, Vol 76(17), pg 5103-14 [PMID:27197191].
  • Nikhil K. Khankari, Wei Zheng, et al.,
    Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.,
    British Journal of Cancer, Aug 2016, Vol 115(5), pg 624-31 [PMID:27490808].
  • Craig C. Teerlink, Lisa Cannon-Albright et al.,
    Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21,
    Hum Genet., Aug 2016, Vol 135(8), pg 923-38 [PMID:27262462].
  • Siddhartha Kar,
    Genome-wide Meta-analyses of Breast, Ovarian and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by At Least Two Cancer Types,
    Cancer Discov., Jul 2016, Vol 6(9), pg 1052-67 [PMID:27432226].
  • Carolina Bonilla, Mari-Anne Rowlands, Sarah J Lewis. et.al.,
    The causal role of insulin-like growth factors IGF-I and IGF-II, and binding proteins IGFBP-2 and IGFBP-3, in prostate cancer: a Mendelian randomization study,
    IJC, May 2016, Vol 139(7), pg 1520-33 [PMID:27225428].
  • Ed Saunders, Zsofia Kote-Jarai et al.,
    Gene and Pathway Level Analyses of the Effect of Germline DNA Repair Gene Variants and Prostate Cancer Susceptibility using the iCOGS Genotyping Array,
    British Journal of Cancer, Apr 2016, Vol 114(8), pg 945-52 [PMID:26964030].
  • Bogdan Pasaniuc, Chris Haiman,
    Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.,
    Nat Commun., Apr 2016, Vol 7, pg 10979 [PMID:27052111].
  • Carolina Bonilla, Sarah J Lewis, Richard M Martin et. Al.,
    Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort,
    BMC Medicine, Apr 2016, Vol 14(1), pg 66 [PMID:27044414].
  • Caroline J Bull,
    Blood lipids and prostate cancer: a Mendelian randomization study,
    Cancer Medicine, Mar 2016, Vol 5(6), pg 1125-36 [PMID:26992435].
  • Yong-Jie Lu et al.,
    Identification of 8q24 as the main genetic risk region of prostate cancer in Chinese men,
    Oncotarget Journal, Feb 2016, Vol 7(16), pg 21393-403 [PMID:26881390].
  • Johanna Schleutker, Teemu Murtola,
    Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin,
    Eur Urol, Dec 2015, Vol 68(6), pg 1089-97 [PMID:25819720].
  • Adam Kibel,
    Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer,
    Cancer Causes and Control, Dec 2015, Vol 26(12), pg 1751-9 [PMID:26407952].
  • Christopher Haiman, David Reich, Bogdan Pasaniuc,
    The contribution of rare variation to prostate cancer heritability,
    Nat Genet., Nov 2015, Vol 48(1), pg 30-5 [PMID:26569126].
  • Deborah Thompson et al.,
    Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA double strand break repair,
    Nat Genet., Sep 2015, Vol 47(11), pg 1294-303 [PMID:26414677].
  • Neil Davies, Richard Martin et al.,
    The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium,
    Cancer Causes and Control, Sep 2015, Vol 26(11), pg 1603-16 [PMID:26387087].
  • Robert Szulkin, Fredrik Wiklund,
    Genome-wide association study of prostate cancer-specific survival,
    CEBP, Aug 2015, Vol 24(11), pg 1796-800 [PMID:26307654].
  • Robert Szulkin, Fredrik Wiklund,
    Prediction of individual genetic risk to prostate cancer using a polygenic score,
    Prostate, Jul 2015, Vol 75(13), pg 1467-1474 [PMID:26177737].
  • A Amin Al Olama, T Dadaev, D Hazelett et al.,
    Fine mapping of common prostate cancer GWAS regions identifies multiple novel association signals,
    Hum Mol Genet, May 2015, Vol 24(19), pg 5589-602 [PMID:26025378].
  • Verena Zuber et al.,
    MicroRNAs Enrichment in GWAS of Complex Human Phenotypes,
    BMC Genomics, Apr 2015, Vol 16, pg 304 [PMID:25884492].
  • Amin Al Olama et al.,
    Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci,
    CEBP, Apr 2015, Vol 24(7), pg 1121-9 [PMID:25837820].
  • Jong Park and Jyotsna Batra,
    A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer,
    Cancer Discov., Feb 2015, Vol 5(4), pg 368-79 [PMID:25691096].
  • Nora Pashayan et al.,
    Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis,
    Genetics in Medicine, Jan 2015, Vol 17(10), pg 789-95 [PMID:25569441].
  • Virpi H. Laitinen, et al. (Johanna Schleutker),
    Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes
    and sequence variants associated with a genetic predisposition
    to prostate cancer,
    IJC, Nov 2014, Vol 136(10), pg 2316-27 [PMID:25335771].
  • Orestis Panagiotou, Konstantinos Tsilidis et al.,
    A genome-wide “pleiotropy scan” for prostate cancer risk,
    European Urology, Sep 2014, Vol 67(4), pg 649-57 [PMID:25277271].
  • A. Amin, Al Olama, Z. Kote-Jarai, Sonja I Berndt et al.,
    A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer,
    Nat Genet., Sep 2014, Vol 46(10), pg 1103-9 [PMID:25217961].
  • Ying Han, Lisa B. Signorello, Sara S. Strom et al.,
    Generalizability of established prostate cancer risk variants in men of African-ancestry,
    IJC, Jul 2014, Vol 136(5), pg 1210-7 [PMID:25044450].
  • Ole Andreassen, Verena Zuber et al.,
    Shared common variants in prostate cancer and blood lipids,
    IJE, Apr 2014, Vol 43(4), pg 1205-14 [PMID:24786909].
  • Ed Saunders et al.,
    Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer,
    PLoS Genet., Feb 2014, Vol 10(2), pg [PMID:24550738].
  • DJ Hazelett, SK Rhie, M Gaddis, RA Eeles et al.,
    Comprehensive functional annotation of 77 prostate cancer risk loci.,
    PLoS Genet, Jan 2014, Vol 10(1), pg [PMID:24497837].
  • Karen A Pooley, Stig E. Bojesen et al.,
    A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk,
    Hum Mol Genet, Jul 2013, Vol 22(24), pg 5056-64 [PMID:23900074].
  • Oriana Yu, Brent Richards, William Foulkes et al.,
    An assessment of the shared allelic architecture between type 2 diabetes and prostate cancer,
    CEBP, May 2013, Vol 22(8), pg 1473-5 [PMID:23704474].
  • Elise Ruark, Sheila Seal, Heather McDonald, et al.,
    Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14,
    Nat Genet., May 2013, Vol 45(6), pg 686-689 [PMID:23666240].
  • Eeles RA, Amin Al Olama A, Benlloch S, et al.,
    Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array,
    Nat Genet., Apr 2013, Vol 45(4), pg 385-91 [PMID:23535732].
  • Kote-Jarai Z, Amin Al Olama A et al.,
    Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression,
    Hum Mol Genet, Mar 2013, Vol 22(12), pg 2520-8 [PMID:23535824].
  • Hui Shen, Brooke L. Fridley, Honglin Song et al.,
    Epigenetic Analysis Leads to Identification of HNF1B as a Subtype-Specific Susceptibility Gene for Ovarian Cancer,
    Nat Commun., Mar 2013, Vol 4, pg 1628 [PMID:23535649].
  • Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al.,
    A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease,
    Hum Mol Genet, Oct 2012, Vol 22(2), pg 408-15 [PMID:23065704].
  • Z. Kote-Jarai, A. Amin Ala Olama, et al.,
    Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study,
    Nat Genet., Jul 2011, Vol 43(8), pg 785-791 [PMID:21743467].
  • Eeles RA et al.,
    Identification of seven novel prostate cancer susceptibility loci through a genome-wide association study,
    Nat Genet., Sep 2009, Vol 41(10), pg 1116-21 [PMID:19767753].
  • Kote-Jarai et al.,
    Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium,
    CEBP, Aug 2008, Vol 17(8), pg 2052-61 [PMID:18708398].